Multiple Myeloma Research Review, Issue 5

In this issue:

Zoledronic acid and the risk of skeletal events
Engraftment and PBSC mobilisation modalities
Late effects of MM and its treatment – Guidelines
Carfilzomib and cardiovascular complications
Network Meta-Analysis as a tool in MM
Adding bortezomib for improved survival and response
The advantages of upfront lower dose lenalidomide
Lenalidomide and the risk of second primary malignancies
Molecular imaging for monitoring and treatment of MM
A revised myeloma comorbidity index

Please login below to download this issue (PDF)